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H3K9 methylation at the E-cadherin promoter is associated with TGF-β–induced EMT in three model cell lines. (A) NMuMG, MCF10A, and 
HMLE cells were treated with TGF-β1 (5 ng/ml) for 3, 9, and 12 days, respectively; cell morphological changes associated with EMT are shown 
in the phase contrast images. Expression of E-cadherin (red) was analyzed by immunofluorescence staining. Nuclei were visualized with DAPI 
staining (blue). Scale bars: 50 μm. (B) NMuMG, MCF10A, and HMLE cells were treated with TGF-β1 (5 ng/ml) for the indicated time periods, 
and expression of E-cadherin (E-cad), claudin-3, claudin-7, Snail, N-cadherin, and vimentin in these cells was analyzed by Western blotting. (C) 
NMuMG, MCF10A, and HMLE cells were treated with TGF-β1 (5 ng/ml) for different time periods, and H3K9me2 and H3K9Ac at the E-cadherin 
promoter in these cell lines were analyzed by ChIP assay.
Downloaded October 21, 2014 from The Journal of Clinical Investigation. doi:10.1172/JCI57349.
research article
1472	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 122      Number 4      April 2012
Downloaded October 21, 2014 from The Journal of Clinical Investigation. doi:10.1172/JCI57349.
research article

















G9a interacts with Snail and forms a complex with Snail and DNMTs. 

































































Loss of E-cadherin expression is associated with elevated H3K9me2 and 





















G9a is critical for TGF-β–induced EMT. (A) Schematic diagram showing 
the position of 3 E-box and CpG dinucleotides at the promoter region 
of E-cadherin. NMuMG cells were treated with TGF-β1 (5 ng/ml) for dif-
ferent time periods, and EMT-mediated methylation of the E-cadherin 
promoter was analyzed by bisulfite sequencing. (B) NMuMG, MCF10A, 
and HMLE cells were treated with TGF-β1 (5 ng/ml) for the indicated 
time periods, and EMT-mediated E-cadherin promoter methylation was 
examined by MSP. m, methylated; u, unmethylated. (C) G9a, Snail, or 
non-target control (NTC) siRNA was expressed in NMuMG cells fol-
lowed by TGF-β treatment for 2 days or cells were treated with 5′-Aza-
dC. Plus and minus signs indicate treatment with and without TGF-β1, 
respectively. The morphological changes are shown in the phase con-
trast images. Expression of E-cadherin, N-cadherin, claudin-7, vimen-
tin, and alternation of lamellipodia (staining with actin-phalloidin) was 
analyzed by immunofluorescence staining. Scale bars: 30 μm.
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G9a is required for H3K9me2 and DNA methylation at the E-cadherin promoter. (A) G9a, Snail, or NTC siRNA was expressed in, or BIX01294 
(BIX; 2.5 μM) was added to NMuMG cells followed by treatment with or without TGF-β1 (5 ng/ml) for 3 days. H3K9me2 and H3K9 acetylation at 
the E-cadherin promoter was analyzed by ChIP. ChIP samples were also analyzed by quantitative real-time PCR (mean ± SD from 3 separate 
experiments; bottom panel). (B) NMuMG cells were treated as described in A. DNA methylation at the E-cadherin promoter was analyzed by 
MSP. Samples from MSP analyses were also analyzed by quantitative real-time PCR, and the ratio of methylated to unmethylated DNA was 
plotted (mean ± SD from 3 separate experiments; bottom panel). (C) NMuMG cells were treated as described in B. The expression of E-cadherin 
mRNA was analyzed by either semi-quantitative RT-PCR (bottom panel) or quantitative real-time PCR (top panel) (mean ± SD from 3 separate 
experiments). (D) NMuMG and MCF10A cells were treated with TGF-β1 for 3 and 12 days, respectively. After immunoprecipitation of endog-
enous Snail, associated endogenous G9a and DNMT1 were analyzed by Western blotting.
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G9a is recruited to the E-cadherin promoter by Snail and results in the 
























G9a forms a complex with Snail and DNMTs. (A) HEK293 cells were transiently coexpressed with Flag-tagged G9a, HA-tagged Snail, and 
Myc-tagged DNMTs. Cell extracts were immunoprecipitated separately with Flag, HA, or Myc antibodies, and the associated G9a, Snail, and 
DNMTs were examined by Western blotting, respectively. (B) Endogenous Snail, G9a, and DNMTs were immunoprecipitated from MDA-MB157, 
BT20, and MDA-MB231 cells, and bound endogenous Snail, G9a, and DNMTs were examined by Western blotting. (C) Snail or NTC siRNA 
was expressed in MDA-MB157 cells, and after immunoprecipitation of endogenous G9a, bound Snail and DNMTs was subjected to Western 
blotting. (D) G9a or NTC siRNA was expressed in MDA-MB157 cells, or cells were treated with the G9a inhibitor BIX01294 (2.5 μM), and after 
immunoprecipitating endogenous Snail, bound DNMTs and G9a were subjected to Western blotting.
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G9a is required for CLBC cell migration and invasion in vitro and tumor 





G9a interacts with Snail directly. (A) Schematic diagram showing the structure of G9a and the different deletion constructs (top panel). HEK293 
cells were transiently coexpressed with plasmids encoding Flag-tagged full-length (FL) or deletion mutants (designated A, B, and C) of G9a and 
HA-tagged Snail. Extracts were immunoprecipitated with Flag or HA antibodies, and bound G9a or Snail was examined by Western blotting. (B) 
Schematic diagram showing the structure of Snail and two deletion mutants (top panel). Full-length and deletion mutants of Snail were coex-
pressed with G9a in HEK293 cells. After immunoprecipitation of G9a, associated Snail was analyzed by Western blotting. ZF, zinc finger.
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G9a-related repressive marks are enriched at the E-cadherin promoter in CLBC cell lines and tumor samples. (A) Cell extracts were prepared 
from 5 luminal and 6 claudin-low subtypes of human breast cancer cell lines, and expression of Snail, G9a, DNMT1, and other EMT markers 
was analyzed by Western blotting. (B) The association of G9a, Snail, and the level of H3K9me2 and H3K9 acetylation at the E-cadherin pro-
moter in various cell lines was analyzed with the ChIP assay. Methylation of the E-cadherin promoter in various breast cell lines was examined 
by MSP (bottom 2 panels). (C) The association of G9a, H3K9me2, and DNA methylation at the E-cadherin promoter in fresh frozen human 
tumor tissues of luminal (25 cases) and triple-negative (16 cases) breast cancer was analyzed by ChIP and MSP, respectively. Statistical analy-
ses (mean ± SD) for the association of G9a (0.26 ± 0.08 versus 1.68 ± 0.44), H3K9me2 (0.18 ± 0.07 versus 1.83 ± 0.6), and DNA methylation 
(0.70 ± 0.13 versus 3.00 ± 0.48) is shown in the distribution plots. TNBC, triple negative breast cancer.
Downloaded October 21, 2014 from The Journal of Clinical Investigation. doi:10.1172/JCI57349.
research article






















Knockdown of G9a expression alters the expression of epithelial and 
mesenchymal markers associated with EMT. Breast cancer is catego-
rized into 6 clinically relevant subtypes based upon molecular gene 
Figure 7
G9a is recruited to the E-cadherin promoter for epigenetic silencing of E-cadherin expression. (A) The association of endogenous G9a, Snail, and 
DNMT1 at the E-cadherin promoter was analyzed by ChIP. (B) G9a, Snail, or NTC siRNA was expressed in MDA-MB157 cells, and the association 
of endogenous G9a, Snail, and DNMT1 at the E-cadherin promoter was analyzed with the ChIP assay. Results of quantitative real-time PCR are 
presented on Supplemental Figure 10. (C) G9a, Snail, or NTC siRNA was expressed in MDA-MB157 cells, or cells were treated with BIX01294 
(2.5 μM); H3K9me2 and H3K9 acetylation at the E-cadherin promoter was analyzed by the ChIP assay. Results of quantitative real-time PCR are 
presented in the right panels (mean ± SD from 3 separate experiments). (D) Statistical analysis of the in vitro G9a methylation assay, mean ± SD 
from 3 independent experiments, is shown. (E) G9a, Snail, or NTC siRNA was expressed in MDA-MB157 and MDA-MB231 cells, or these cells 
were treated with the DNMT inhibitor 5′-Aza-dC (5′-Aza; 10 μM), and DNA methylation at the E-cadherin promoter was analyzed by MSP. Ctrl, 
control. (F) Statistical analysis of the in vitro DNA methylation assay, mean ± SD from 3 independent experiments, is shown.
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Figure 8
Knockdown of G9a expression inhibits breast cancer cell migration and invasion in vitro. (A) MDA-MB231 cells stably expressing control vector 
or G9a shRNA were examined for the expression of G9a, E-cadherin, and vimentin by Western blotting. (B) Morphological changes in MDA-
MB231 cells and stable transfectants with knockdown of G9a are shown in the phase contrast images. Expression of E-cadherin and vimentin 
in these cells was analyzed by immunofluorescence staining. Nuclei were stained with DAPI (blue). Scale bars: 25 μm. (C) The migratory ability 
of MDA-MB231 cells and the corresponding stable transfectants with knockdown of G9a expression was analyzed by wound healing assay. 
Statistical analysis for the cell migration is shown in the bar graph (mean ± SD from 3 independent experiments), and a representative experi-
ment is shown in the right panel. Scale bars: 100 μm. (D) The invasiveness of MDA-MB231 cells stably expressing control vector or G9a shRNA 
was analyzed with a modified Boyden chamber invasion assay. The percentage of invasive cells is shown in the bar graph (mean ± SD from 
3 separate experiments), and a representative experiment is shown in the right panel. Scale bars: 10 μm.
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Knockdown of G9a expression suppresses breast tumor growth and lung colonization in vivo. (A) MDA-MB231 cells stably expressing control 
vector or G9a shRNA were injected into the mammary fat pad of ICR-SCID mice. The growth of breast tumors was monitored every 3 days. After 
9 weeks, the size of tumors from each group was recorded by using bioluminescence imaging and quantified by measuring photon flux. Values 
are the mean of 6 animals ± SEM. (B) Cells from A were also injected into the tail vein of ICR-SCID mice. After 9 weeks, the development of 
lung metastases was recorded using bioluminescence imaging and quantified by measuring photon flux (mean of 6 animals ± SEM). Results for 
3 representative mice from each group are shown. Mice were sacrificed, and lung metastatic nodules were examined macroscopically or 
detected in paraffin-embedded sections stained with H&E. Scale bars: 100 μm. Arrowheads indicate lung metastases.
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Knockdown of G9a expression alters the expression of epithelial and mesenchymal markers associated with EMT. (A) The differentially 
expressed markers for EMT and basal and luminal breast cancer from MDA-MB231 cells and the corresponding stable clone with knockdown 
of G9a expression were analyzed by quantitative RT-PCR. (B) Kaplan-Meier overall survival curve separates the tumors (from GSE1456) into 
3 groups with expression of a 9-gene prognostic signature (top panel). Expression of the 9-gene signature in 159 breast cancer patients is shown 
in the heatmap (bottom panel). Top bars: tumor grade (1: blue, 2: pink, 3: red) and tumor subtypes (normal-like: blue, luminal A: yellow, luminal B: 
orange, basal: pink, HER2-positive: red]). P1, probe 1; P2, probe 2. (C) A proposed model to illustrate the interaction of Snail with G9a and 
DNMTs leading to E-cadherin promoter methylation and EMT induction (see Discussion).
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Immunostaining, immunoprecipitation, and immunoblotting. Experiments were 
performed as described previously (25). For immunofluorescence staining, 
cells were grown on chamber slides, fixed with 4% paraformaldehyde, and 
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